PL2512453T5 - Granulki do preparatów farmaceutycznych, sposoby i urządzenie do ich wytwarzania - Google Patents
Granulki do preparatów farmaceutycznych, sposoby i urządzenie do ich wytwarzaniaInfo
- Publication number
- PL2512453T5 PL2512453T5 PL10793226.1T PL10793226T PL2512453T5 PL 2512453 T5 PL2512453 T5 PL 2512453T5 PL 10793226 T PL10793226 T PL 10793226T PL 2512453 T5 PL2512453 T5 PL 2512453T5
- Authority
- PL
- Poland
- Prior art keywords
- granules
- production
- methods
- devices
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/609—Amides, e.g. salicylamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09179877A EP2340812A1 (de) | 2009-12-18 | 2009-12-18 | Granulat für pharmazeutische Präparate sowie Verfahren und Vorrichtungen zu ihrer Herstellung |
| PCT/EP2010/069733 WO2011073245A2 (en) | 2009-12-18 | 2010-12-15 | Granules for pharmaceutical preparations, methods and apparatus for their production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL2512453T3 PL2512453T3 (pl) | 2017-03-31 |
| PL2512453T5 true PL2512453T5 (pl) | 2025-07-07 |
Family
ID=42110308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10793226.1T PL2512453T5 (pl) | 2009-12-18 | 2010-12-15 | Granulki do preparatów farmaceutycznych, sposoby i urządzenie do ich wytwarzania |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US8765185B2 (de) |
| EP (2) | EP2340812A1 (de) |
| JP (1) | JP5593396B2 (de) |
| KR (1) | KR101882880B1 (de) |
| CN (2) | CN105769772A (de) |
| AR (1) | AR079536A1 (de) |
| AU (1) | AU2010332884B2 (de) |
| BR (1) | BR112012014935B1 (de) |
| CA (1) | CA2784235C (de) |
| DK (1) | DK2512453T4 (de) |
| ES (1) | ES2612870T5 (de) |
| FI (1) | FI2512453T4 (de) |
| HR (1) | HRP20161639T4 (de) |
| HU (1) | HUE031228T2 (de) |
| IL (1) | IL220319A (de) |
| JO (1) | JO3762B1 (de) |
| LT (1) | LT2512453T (de) |
| MX (2) | MX351365B (de) |
| NL (1) | NL1038373C2 (de) |
| NZ (1) | NZ600582A (de) |
| PL (1) | PL2512453T5 (de) |
| PT (1) | PT2512453T (de) |
| RS (1) | RS55438B2 (de) |
| RU (1) | RU2584349C2 (de) |
| SI (1) | SI2512453T2 (de) |
| TW (1) | TWI511723B (de) |
| WO (1) | WO2011073245A2 (de) |
| ZA (1) | ZA201204441B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070042143A1 (en) * | 2003-04-23 | 2007-02-22 | Ferring B.V. | Sachet for a pharmaceutical composition |
| ES2972135T3 (es) | 2008-10-02 | 2024-06-11 | Salix Pharmaceuticals Inc | Tratamiento de encefalopatía hepática usando rifaximina |
| EP2340812A1 (de) | 2009-12-18 | 2011-07-06 | Ferring International Center S.A. | Granulat für pharmazeutische Präparate sowie Verfahren und Vorrichtungen zu ihrer Herstellung |
| US20140141075A1 (en) | 2012-11-21 | 2014-05-22 | Warner Chilcott Company, Llc | 5-aminosalicylic acid capsule formulation |
| DE202017102645U1 (de) * | 2017-05-03 | 2018-08-06 | Romaco Kilian Gmbh | Ablaufvorrichtung für Presslinge einer Rundläufer-Tablettenpresse sowie Rundläufer-Tablettenpresse mit Ablaufvorrichtung |
| RU2667637C1 (ru) * | 2017-06-26 | 2018-09-21 | Гермес Арцнаймиттель ГмбХ | Фармацевтическая композиция для перорального применения, содержащая n-ацетилцистеин с маскированным вкусом |
| EP3459527B1 (de) | 2017-09-20 | 2022-11-23 | Tillotts Pharma Ag | Verfahren zur herstellung einer festen dosierungsform mit antikörpern durch nassgranulation, -extrusion und -sphäronisierung |
| ES2938609T3 (es) | 2017-09-20 | 2023-04-13 | Tillotts Pharma Ag | Preparación de formas farmacéuticas sólidas que comprenden anticuerpos mediante estratificación de solución/suspensión |
| EP3459529A1 (de) | 2017-09-20 | 2019-03-27 | Tillotts Pharma Ag | Herstellung von festen darreichungsformen mit verzögerter freisetzung mit antikörpern durch sprühtrocknung |
| KR102161235B1 (ko) * | 2020-07-22 | 2020-09-29 | 주식회사 피티케이 | 이송 일체형 과립 제조 장치 및 방법 |
| JP7296600B2 (ja) * | 2020-08-18 | 2023-06-23 | ユーハ味覚糖株式会社 | 口中速崩壊性固形食品及びその製造方法 |
| CN114472139A (zh) * | 2022-01-04 | 2022-05-13 | 安徽宏信药业发展有限公司 | 一种中药药丸干燥筛选装置 |
| CN115445902B (zh) * | 2022-09-21 | 2023-06-06 | 重庆科技学院 | 一种条形颗粒物三维尺寸分选方法及装置 |
| WO2024200722A1 (en) | 2023-03-28 | 2024-10-03 | Tillotts Pharma Ag | Solid oral dosage form comprising antibodies for sustained release in the lower gastrointestinal tract |
| CN116942532B (zh) * | 2023-09-20 | 2023-12-12 | 北京爱力佳医药科技有限公司 | 一种粉状药物制备装置 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1981002671A1 (en) | 1980-03-20 | 1981-10-01 | Ferring Farma Lab | Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration |
| EP0274479B1 (de) | 1986-03-10 | 1993-07-14 | Cri International, Inc. | Verfahren zur Sortierung und Isolierung von Katalysator-Formteilchen nach ihrer Länge |
| US4720473A (en) * | 1986-03-10 | 1988-01-19 | Cri International, Inc. | Production of improved catalyst-type particles using length and density grading |
| JPH0827133B2 (ja) | 1993-07-13 | 1996-03-21 | 不二パウダル株式会社 | 湿潤粉粒体の処理装置 |
| KR100542544B1 (ko) | 1995-12-21 | 2006-05-10 | 파마슈티스크 라보라토리움 페링 에이/에스 | 5-아미노살리실산을함유하는방출제어형경구용약제학적조성물및장질환을치료하는방법 |
| US6004581A (en) | 1995-12-21 | 1999-12-21 | Farmaceutisk Laboratorium Ferring A/S | Modified release oral pharmaceutical composition and method for the treatment of bowel diseases |
| AUPO637197A0 (en) | 1997-04-23 | 1997-05-15 | F.H. Faulding & Co. Limited | Taste-masked pharmaceutical compositions |
| DE19724181A1 (de) * | 1997-06-09 | 1998-12-10 | Bayer Ag | Multiple-unit-retard-Zubereitungen und Verfahren zu ihrer Herstellung |
| JP2000128774A (ja) | 1998-10-26 | 2000-05-09 | Tanabe Seiyaku Co Ltd | 薬物を含有する球形微粒子の製法 |
| US6146685A (en) | 1998-11-05 | 2000-11-14 | Delsys Pharmaceutical Corporation | Method of deposition a dry powder and dispensing device |
| NZ513037A (en) * | 1999-01-29 | 2003-05-30 | Disphar Internat B | Coated sustained release pharmaceutical composition for the release of an agent in the gastrointestinal tract |
| US6735487B1 (en) | 1999-07-01 | 2004-05-11 | Ods Properties, Inc. | Interactive wagering system with promotions |
| GB0113841D0 (en) * | 2001-06-07 | 2001-08-01 | Boots Co Plc | Therapeutic agents |
| ATE371441T1 (de) * | 2001-10-15 | 2007-09-15 | Ferring Bv | Verfahren zur herstellung einer pharmazeutischen zubereitung mit 5-aminosalicylsäure zur verwendung bei der behandlung von colitis ulcerosa und morbus crohn |
| US8282955B2 (en) | 2001-10-15 | 2012-10-09 | Ferring B.V. | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease |
| US7445796B2 (en) | 2002-08-19 | 2008-11-04 | L. Perrigo Company | Pharmaceutically active particles of a monomodal particle size distribution and method |
| US20070042143A1 (en) * | 2003-04-23 | 2007-02-22 | Ferring B.V. | Sachet for a pharmaceutical composition |
| EP1470819A1 (de) * | 2003-04-23 | 2004-10-27 | Ferring B.V. | Sachet mit hohem Anteil an Mesalazin |
| EP1547601A1 (de) | 2003-12-23 | 2005-06-29 | Ferring B.V. | Beschichtungsverfahren |
| US7207505B2 (en) | 2004-06-04 | 2007-04-24 | Bender Martin P | Method for producing small granules |
| DE102004028977A1 (de) * | 2004-06-16 | 2006-01-05 | Add Advanced Drug Delivery Technologies Ltd. | Neutralpellets |
| JP2009521402A (ja) | 2005-11-17 | 2009-06-04 | テバ ファーマシューティカル インダストリーズ リミティド | プロパルギル化アミノインダンの分離のための方法 |
| EP2340812A1 (de) | 2009-12-18 | 2011-07-06 | Ferring International Center S.A. | Granulat für pharmazeutische Präparate sowie Verfahren und Vorrichtungen zu ihrer Herstellung |
-
2009
- 2009-12-18 EP EP09179877A patent/EP2340812A1/de not_active Withdrawn
-
2010
- 2010-11-10 NL NL1038373A patent/NL1038373C2/en not_active IP Right Cessation
- 2010-12-15 FI FIEP10793226.1T patent/FI2512453T4/fi active
- 2010-12-15 BR BR112012014935-0A patent/BR112012014935B1/pt active IP Right Grant
- 2010-12-15 MX MX2014011350A patent/MX351365B/es unknown
- 2010-12-15 AU AU2010332884A patent/AU2010332884B2/en active Active
- 2010-12-15 RS RS20161111A patent/RS55438B2/sr unknown
- 2010-12-15 HU HUE10793226A patent/HUE031228T2/en unknown
- 2010-12-15 SI SI201031345T patent/SI2512453T2/sl unknown
- 2010-12-15 KR KR1020127018413A patent/KR101882880B1/ko active Active
- 2010-12-15 LT LTEP10793226.1T patent/LT2512453T/lt unknown
- 2010-12-15 MX MX2012006851A patent/MX2012006851A/es active IP Right Grant
- 2010-12-15 RU RU2012124834/15A patent/RU2584349C2/ru active
- 2010-12-15 WO PCT/EP2010/069733 patent/WO2011073245A2/en not_active Ceased
- 2010-12-15 DK DK10793226.1T patent/DK2512453T4/da active
- 2010-12-15 CA CA2784235A patent/CA2784235C/en active Active
- 2010-12-15 EP EP10793226.1A patent/EP2512453B2/de active Active
- 2010-12-15 JP JP2012543713A patent/JP5593396B2/ja active Active
- 2010-12-15 CN CN201610133023.9A patent/CN105769772A/zh active Pending
- 2010-12-15 US US13/516,145 patent/US8765185B2/en active Active
- 2010-12-15 JO JOP/2010/0446A patent/JO3762B1/ar active
- 2010-12-15 CN CN201080063456.2A patent/CN102791257B/zh active Active
- 2010-12-15 ES ES10793226T patent/ES2612870T5/es active Active
- 2010-12-15 HR HRP20161639TT patent/HRP20161639T4/hr unknown
- 2010-12-15 NZ NZ600582A patent/NZ600582A/en unknown
- 2010-12-15 PT PT107932261T patent/PT2512453T/pt unknown
- 2010-12-15 PL PL10793226.1T patent/PL2512453T5/pl unknown
- 2010-12-17 TW TW099144475A patent/TWI511723B/zh active
- 2010-12-20 AR ARP100104755A patent/AR079536A1/es not_active Application Discontinuation
-
2012
- 2012-06-12 IL IL220319A patent/IL220319A/en active IP Right Grant
- 2012-06-15 ZA ZA2012/04441A patent/ZA201204441B/en unknown
-
2014
- 2014-05-16 US US14/279,806 patent/US9114083B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2512453T5 (pl) | Granulki do preparatów farmaceutycznych, sposoby i urządzenie do ich wytwarzania | |
| HUE062860T2 (hu) | Magas koncentrációjú gyógyszerészeti készítmények | |
| IL245328A0 (en) | Pharmaceutical composition | |
| DK2729151T3 (da) | Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf | |
| BR112012011902A2 (pt) | cápsula farmacêutica | |
| IL243932A0 (en) | Certain chemical entities, compositions and methods | |
| DK2479174T3 (da) | 6-aminoquinazolin- eller 3-cyanquinolinderivater, fremstillingsfremgangsmåder og farmaceutiske anvendelser deraf | |
| DK2699397T3 (da) | Apparater, system og fremgangsmåder til at danne pressede artikler og pressede artikler dannet derved | |
| IL222930B (en) | Chlorotoxin variants, conjugates and methods for their use | |
| DK2756073T3 (da) | Manipuleret væv til in vitro-forskningsanvendelser, anordninger deraf og fremgangsmåder til fremstilling deraf | |
| DK3415157T3 (da) | N-acyldipeptidderivater og anvendelser deraf | |
| SMT201400069B (it) | Formulazione farmaceutica | |
| EP2481739A4 (de) | Dihydropteridinonderivate, herstellungsverfahren dafür und pharmazeutische anwendung davon | |
| IL230838A0 (en) | Pharmaceutical compositions | |
| IL223463A (en) | Urea History, Pharmaceutical Preparations Containing and Uses | |
| GT201200303A (es) | Formulaciones farmacéuticas | |
| BRPI1005433A2 (pt) | preparações farmacêuticas transdérmicas | |
| DK2544986T3 (da) | System og fremgangsmåde til aseptisk dosering | |
| BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados | |
| BR112013009579A2 (pt) | método e comprimido | |
| CO6910193A2 (es) | Derivados de anilina, su preparación y su aplicación terapéutica | |
| BRPI0922653A2 (pt) | preparação farmacêutica | |
| DK2488043T3 (da) | Forbedret ernæringstablet | |
| DK3210990T3 (da) | Levoisovalerylspiramycin iii og præparater, fremstillingsfremgangsmåder og anvendelser deraf | |
| BR112013008074A2 (pt) | combinações farmacêuticas |